Foster Dykema Cabot & Partners’s ResMed RMD Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.2K	Hold	124	–	–	﹤0.01%	224
2026 Q1	$27.8K	Hold	124	–	–	﹤0.01%	215
2025 Q4	$29.9K	Sell	124 -42	-25%	-$10.7K	﹤0.01%	222
2025 Q3	$45.4K	Hold	166	–	–	﹤0.01%	217
2025 Q2	$42.8K	Hold	166	–	–	﹤0.01%	204
2025 Q1	$37.2K	Hold	166	–	–	﹤0.01%	209
2024 Q4	$38K	Sell	166 -134	-45%	-$32.3K	﹤0.01%	220
2024 Q3	$73.2K	Sell	300 -320	-52%	-$71.5K	0.01%	188
2024 Q2	$119K	Buy	+620	New	+$126K	0.01%	135

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Foster Dykema Cabot & Partners's RMD Position: Q2 2026 in Review

Foster Dykema Cabot & Partners held its ResMed (RMD) position steady in Q2 2026 at 124 shares worth $24.2K. The position accounts for ﹤0.01% of the portfolio, ranked #224.

Foster Dykema Cabot & Partners first reported a position in RMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $119K in Q2 2024. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Foster Dykema Cabot & Partners held 124 shares of ResMed worth $24.2K as of Q2 2026.
Foster Dykema Cabot & Partners left its ResMed share count unchanged in Q2 2026.
ResMed made up ﹤0.01% of Foster Dykema Cabot & Partners's portfolio in Q2 2026, its #224 holding.
Foster Dykema Cabot & Partners first reported a position in ResMed in Q2 2024 and has held it in 9 quarters since.
Foster Dykema Cabot & Partners's ResMed position peaked at $119K in Q2 2024.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q2 2026, filed 11 Aug 2026.